focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Share News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.20
Bid: 4.20
Ask: 4.30
Change: -0.13 (-3.00%)
Spread: 0.10 (2.381%)
Open: 4.20
High: 4.20
Low: 4.20
Prev. Close: 4.33
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Plant Health Care Warns Full-Year Revenue To Lag Behind Expectations

Mon, 30th Sep 2019 14:54

(Alliance News) - Plant Health Care PLC on Monday reported a narrowed first half loss, but revenue fell year-on-year after a delay to an order in Brazil.

The agriculture-focused biological products maker generated first-half revenue of USD2.7 million, down 11% from USD3.0 million in the first half of 2018. Its pretax loss narrowed to USD2.8 million from USD5.0 million.

Research & development costs fell by 42% to USD1.4 million from USD2.4 million, with sales & marketing fees down by 23% to USD1.6 million from USD2.1 million and administrative expenses reduced by 37% to USD1.4 million from USD2.3 million.

Plant Health said that a USD500,000 order in Brazil "fell into July due to import licence delays", the shift contributing to the fall in six-month revenue to June 30.

During the period, the company reported that trials of its PREtec peptides, to deal with Asian soybean rust in crops in Brazil, the US and Europe, showed "strong results".

Plant Health added: "The group has made good progress towards preparing for direct sales of PREtec peptides, targeting markets worth more than USD5 billion. Registration is progressing and production of PREtec peptides is now scaling up from laboratory to pilot scale."

Looking ahead, Plant Health warned that full-year revenue will be lower than initially forecast. It still expects year-on-year revenue growth, however, despite "macro-level market-driven challenges". The company generated revenue of USD8.1 million in 2018.

Shares were untraded in London on Monday afternoon, last quoted at 6.50 pence each.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
23 Sep 2013 09:37

DIRECTOR DEALINGS: Plant Health Care Non-Exec Buys 21K Shares

Read more
18 Sep 2013 14:26

DIRECTOR DEALINGS: Plant Health Care Non Executive Granted Options

Read more
16 Sep 2013 09:41

Plant Health Care Loss Widens, But Revenues Rise

Read more
7 May 2013 16:19

Telecity CEO sells shares as update impresses

Michael Tobin, the Chief Executive Officer of data centre operator Telecity, has sold 124,105 shares following the exercise of options over 125,105 shares, taking his stake to 666,000. The shares were traded in at 949.50p each, earning the director in the region of £1.18m. The deal was made on t

Read more
1 May 2013 15:59

Carphone Warehouse heads partake in placing to fund acquisition

The Chairman, Chief Executive, and Chief Financial Officer (CFO) of mobile phones retailer Carphone Warehouse have all purchased shares as part of a placing, the proceeds of which are being used in part to fund the proposed acquisition of the remaining 50 per cent stake in CPW Europe. Sir Charles

Read more
25 Apr 2013 09:05

Plant Health Care secures Arysta commercialisation deal - UPDATE

Plant Health Care (PHC), the developer of naturally derived agricultural products, has secured a long-awaited commercial contract with agrichemicals giant Arysta LifeScience Corporation. Following on from a research agreement between the two companies, the pair have agreed to develop and commercia

Read more
20 Mar 2013 13:09

Plant Health Cares receives payment as partner reaches milestone

Shares in Plant Health Care (PHC) jumped on Wednesday after the company said that it will receive a payment after one of its partners reached a project milestone. PHC, the AIM-listed provider of biological products to the agriculture markets, said that Germains Seed Technology, its partner in devel

Read more
11 Mar 2013 12:27

Plant Health warns on partnership revenues

Plant Health Care, the AIM-listed provider of naturally derived products to the agriculture industry, has warned that although it expects good growth in partnership revenues in the current year and next, these will be at lower levels than currently indicated by market forecasts. The announcement c

Read more
24 Jan 2013 09:39

Plant Health Care seed test trials produce positive results

Biological products provider Plant Health Care has unveiled striking results relating to its Harpin seed trials. In a trading update providing details of its Harpin field trials, the group stated that the Harpin seed treatment had delivered substantial yield increases when combined with industry st

Read more
10 Jan 2013 14:09

Plant Health Care says annual losses lower than expected

Plant Health Care said on Thursday it expects annual results to show an operating loss 'slightly better than expectations'. In a trading update, the provider of novel patent protected biological products to the global agriculture markets projected an operating loss of $6.5m for the year to the end

Read more
9 Oct 2012 10:37

Plant Health Care delivers 'outstanding' results

Plant Health Care, a provider of innovative patent protected biological products to the global agriculture markets, has reported strong first sales of a novel approach to fungicide resistance management. Its ProAct product was applied to around 200,000 acres of crops in the US this season, produc

Read more
13 Sep 2012 13:52

Small caps round-up: Manroy, Plant Health Care, Goals Soccer Centres

Six-a-side football pitches operator Goals Soccer Centres has won an appeal against a ruling made by HMRC, resulting in a boost to full year profits. Earlier in the year HMRC issued a business brief relating to the five-a-side soccer industry, indicating that all income relating to commercially oper

Read more
24 Aug 2012 16:24

SDL non-exec takes up only holding in firm

Mandy Gradden, a non-executive director of SDL, the FTSE 250 information management firm, bought up 7,500 shares on Thursday, just over a week after the company unveiled a 20 per cent leap in first-half revenues. Gradden's purchase, in which she bought the shares at 658p each for a total of £49,35

Read more
20 Aug 2012 09:16

Plant Health Care pleases as losses narrow

Plant Health Care, a producer of 'naturally derived' agricultural products, has reported flat revenue for the half year ended June 30th with sales of its Harpin and Myoconate products up 49 per cent in a period of 'significant change' for the sector. The loss before tax for the period came in slig

Read more
27 Jul 2012 10:20

Spuds-u-like Plant Health Care's Harpin

Plant Health Care's Harpin crop-productivity technology has been shown in tests to increase the marketable yield when used on potatoes. The company, which uses natural biological solutions to modify how plants grow, saw its share price enjoy its own growth spurt as it revealed that recent trials by

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.